MACS CARDIOVASCULAR SUBSTUDY HIV

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 “多中心艾滋病队列研究”（MACS）是一项大型的、长期的男性人类免疫缺陷病毒（HIV）/艾滋病自然史研究。近年来，美国的艾滋病毒/艾滋病流行情况发生了变化：高效抗逆转录病毒疗法（HAART）减少了艾滋病毒相关并发症，延长了生存期。然而，有些人从HAART发展副作用，如体型变化，高胆固醇和甘油三酯（血液中的脂肪），和/或高血糖/糖尿病。目前尚不清楚这些副作用或慢性HIV感染本身是否会影响心脏病的发病率。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The "Multicenter AIDS Cohort Study" (MACS) is a large, long term study of the natural history of human immunodeficiency virus (HIV)/AIDS in men. In recent years, the HIV/AIDS epidemic in the United States has changed: highly active antiretroviral therapy (HAART) has led to fewer HIV-related complications and longer survival. However, some people develop side effects from HAART such as body shape changes, high cholesterol and triglycerides (fats in the blood), and/or high blood sugar/diabetes mellitus. It is not known if these side effects, or chronic HIV infection itself, will affect rates of heart disease.